Logan A. Walsh
Logan A. Walsh
Assistant Professor, Goodman Cancer Research Centre and Dept of Human Genetics, McGill University
Verified email at
Cited by
Cited by
Genetic basis for clinical response to CTLA-4 blockade in melanoma
A Snyder, V Makarov, T Merghoub, J Yuan, JM Zaretsky, A Desrichard, ...
New England Journal of Medicine 371 (23), 2189-2199, 2014
IDH1 mutation is sufficient to establish the glioma hypermethylator phenotype
S Turcan, D Rohle, A Goenka, LA Walsh, F Fang, E Yilmaz, C Campos, ...
Nature 483 (7390), 479-483, 2012
The mutational landscape of adenoid cystic carcinoma
AS Ho, K Kannan, DM Roy, LGT Morris, I Ganly, N Katabi, D Ramaswami, ...
Nature genetics 45 (7), 791-798, 2013
Recurrent somatic mutation of FAT1 in multiple human cancers leads to aberrant Wnt activation
LGT Morris, AM Kaufman, Y Gong, D Ramaswami, LA Walsh, Ş Turcan, ...
Nature genetics 45 (3), 253-261, 2013
Obesity alters the lung myeloid cell landscape to enhance breast cancer metastasis through IL5 and GM-CSF
DF Quail, OC Olson, P Bhardwaj, LA Walsh, L Akkari, ML Quick, IC Chen, ...
Nature cell biology 19 (8), 974-987, 2017
Primary tumors induce neutrophil extracellular traps with targetable metastasis-promoting effects
RF Rayes, JG Mouhanna, I Nicolau, F Bourdeau, B Giannias, S Rousseau, ...
JCI insight 4 (16), 2019
Driver mutations of cancer epigenomes
DM Roy, LA Walsh, TA Chan
Protein & cell 5 (4), 265-296, 2014
Comprehensive molecular characterization of salivary duct carcinoma reveals actionable targets and similarity to apocrine breast cancer
MG Dalin, A Desrichard, N Katabi, V Makarov, LA Walsh, KW Lee, ...
Clinical cancer research 22 (18), 4623-4633, 2016
Recurrent SERPINB3 and SERPINB4 mutations in patients who respond to anti-CTLA4 immunotherapy
N Riaz, JJ Havel, SM Kendall, V Makarov, LA Walsh, A Desrichard, ...
Nature genetics 48 (11), 1327-1329, 2016
IGF-1 increases invasive potential of MCF 7 breast cancer cells and induces activation of latent TGF-β1 resulting in epithelial to mesenchymal transition
LA Walsh, S Damjanovski
Cell Communication and Signaling 9, 1-11, 2011
Rapamycin suppresses self-renewal and vasculogenic potential of stem cells isolated from infantile hemangioma
S Greenberger, S Yuan, LA Walsh, E Boscolo, KT Kang, B Matthews, ...
Journal of investigative dermatology 131 (12), 2467-2476, 2011
Single-cell spatial immune landscapes of primary and metastatic brain tumours
E Karimi, MW Yu, SM Maritan, LJM Perus, M Rezanejad, M Sorin, ...
Nature 614 (7948), 555-563, 2023
Single-cell spatial landscapes of the lung tumour immune microenvironment
M Sorin, M Rezanejad, E Karimi, B Fiset, L Desharnais, LJM Perus, ...
Nature 614 (7948), 548-554, 2023
An integrated systems biology approach identifies TRIM25 as a key determinant of breast cancer metastasis
LA Walsh, MJ Alvarez, EY Sabio, M Reyngold, V Makarov, S Mukherjee, ...
Cell reports 20 (7), 1623-1640, 2017
Discoidin domain receptor 2 is a critical regulator of epithelial–mesenchymal transition
LA Walsh, A Nawshad, D Medici
Matrix Biology 30 (4), 243-247, 2011
Multi-dimensional genomic analysis of myoepithelial carcinoma identifies prevalent oncogenic gene fusions
MG Dalin, N Katabi, M Persson, KW Lee, V Makarov, A Desrichard, ...
Nature communications 8 (1), 1197, 2017
Microenvironmental heterogeneity in brain malignancies
LJM Perus, LA Walsh
Frontiers in immunology 10, 482096, 2019
Neutrophil oxidative stress mediates obesity-associated vascular dysfunction and metastatic transmigration
SAC McDowell, RBE Luo, A Arabzadeh, S Doré, NC Bennett, V Breton, ...
Nature Cancer 2 (5), 545-562, 2021
Candidate prognostic markers in breast cancer: focus on extracellular proteases and their inhibitors
DM Roy, LA Walsh
Breast Cancer: Targets and Therapy, 81-91, 2014
Integrated genomics for pinpointing survival loci within arm-level somatic copy number alterations
DM Roy, LA Walsh, A Desrichard, JT Huse, W Wu, JJ Gao, P Bose, W Lee, ...
Cancer cell 29 (5), 737-750, 2016
The system can't perform the operation now. Try again later.
Articles 1–20